United States Remodulin Market Report 2016

November 2016 | 97 pages | ID: U0B8203EFDEEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Remodulin

Revenue, means the sales value of Remodulin

This report studies sales (consumption) of Remodulin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer HealthCare Pharmaceuticals (Germany)
• GlaxoSmithKline Plc (UK)
• Eli Lilly and Company (US)
• Gilead Sciences, Inc. (US)
• Sanofi S.A (France)
• Nippon Shinyaku Co., Ltd. (Japan)
• United Therapeutics Corp. (US)
• Cipla Limited (India)
• Actelion Pharmaceuticals Ltd. (Switzerland)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Remodulin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Remodulin Market Report 2016

1 REMODULIN OVERVIEW

1.1 Product Overview and Scope of Remodulin
1.2 Classification of Remodulin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Remodulin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Remodulin (2011-2021)
  1.4.1 United States Remodulin Sales and Growth Rate (2011-2021)
  1.4.2 United States Remodulin Revenue and Growth Rate (2011-2021)

2 UNITED STATES REMODULIN COMPETITION BY MANUFACTURERS

2.1 United States Remodulin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Remodulin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Remodulin Average Price by Manufactures (2015 and 2016)
2.4 Remodulin Market Competitive Situation and Trends
  2.4.1 Remodulin Market Concentration Rate
  2.4.2 Remodulin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES REMODULIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Remodulin Sales and Market Share by Type (2011-2016)
3.2 United States Remodulin Revenue and Market Share by Type (2011-2016)
3.3 United States Remodulin Price by Type (2011-2016)
3.4 United States Remodulin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES REMODULIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Remodulin Sales and Market Share by Application (2011-2016)
4.2 United States Remodulin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES REMODULIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Remodulin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer HealthCare Pharmaceuticals (Germany)
  5.2.2 Remodulin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer HealthCare Pharmaceuticals (Germany) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc (UK)
  5.3.2 Remodulin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc (UK) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eli Lilly and Company (US)
  5.4.2 Remodulin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eli Lilly and Company (US) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Gilead Sciences, Inc. (US)
  5.5.2 Remodulin Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Gilead Sciences, Inc. (US) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sanofi S.A (France)
  5.6.2 Remodulin Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sanofi S.A (France) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Nippon Shinyaku Co., Ltd. (Japan)
  5.7.2 Remodulin Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Nippon Shinyaku Co., Ltd. (Japan) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 United Therapeutics Corp. (US)
  5.8.2 Remodulin Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 United Therapeutics Corp. (US) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Cipla Limited (India)
  5.9.2 Remodulin Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Cipla Limited (India) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Actelion Pharmaceuticals Ltd. (Switzerland)
  5.10.2 Remodulin Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Actelion Pharmaceuticals Ltd. (Switzerland) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 REMODULIN MANUFACTURING COST ANALYSIS

6.1 Remodulin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Remodulin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Remodulin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Remodulin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES REMODULIN MARKET FORECAST (2016-2021)

10.1 United States Remodulin Sales, Revenue Forecast (2016-2021)
10.2 United States Remodulin Sales Forecast by Type (2016-2021)
10.3 United States Remodulin Sales Forecast by Application (2016-2021)
10.4 Remodulin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Remodulin
Table Classification of Remodulin
Figure United States Sales Market Share of Remodulin by Type in 2015
Table Application of Remodulin
Figure United States Sales Market Share of Remodulin by Application in 2015
Figure United States Remodulin Sales and Growth Rate (2011-2021)
Figure United States Remodulin Revenue and Growth Rate (2011-2021)
Table United States Remodulin Sales of Key Manufacturers (2015 and 2016)
Table United States Remodulin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Remodulin Sales Share by Manufacturers
Figure 2016 Remodulin Sales Share by Manufacturers
Table United States Remodulin Revenue by Manufacturers (2015 and 2016)
Table United States Remodulin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Remodulin Revenue Share by Manufacturers
Table 2016 United States Remodulin Revenue Share by Manufacturers
Table United States Market Remodulin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Remodulin Average Price of Key Manufacturers in 2015
Figure Remodulin Market Share of Top 3 Manufacturers
Figure Remodulin Market Share of Top 5 Manufacturers
Table United States Remodulin Sales by Type (2011-2016)
Table United States Remodulin Sales Share by Type (2011-2016)
Figure United States Remodulin Sales Market Share by Type in 2015
Table United States Remodulin Revenue and Market Share by Type (2011-2016)
Table United States Remodulin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Remodulin by Type (2011-2016)
Table United States Remodulin Price by Type (2011-2016)
Figure United States Remodulin Sales Growth Rate by Type (2011-2016)
Table United States Remodulin Sales by Application (2011-2016)
Table United States Remodulin Sales Market Share by Application (2011-2016)
Figure United States Remodulin Sales Market Share by Application in 2015
Table United States Remodulin Sales Growth Rate by Application (2011-2016)
Figure United States Remodulin Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Remodulin Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Remodulin Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Remodulin Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Remodulin Sales Market Share (2011-2016)
Table Gilead Sciences, Inc. (US) Basic Information List
Table Gilead Sciences, Inc. (US) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences, Inc. (US) Remodulin Sales Market Share (2011-2016)
Table Sanofi S.A (France) Basic Information List
Table Sanofi S.A (France) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A (France) Remodulin Sales Market Share (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List
Table Nippon Shinyaku Co., Ltd. (Japan) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Remodulin Sales Market Share (2011-2016)
Table United Therapeutics Corp. (US) Basic Information List
Table United Therapeutics Corp. (US) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corp. (US) Remodulin Sales Market Share (2011-2016)
Table Cipla Limited (India) Basic Information List
Table Cipla Limited (India) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Limited (India) Remodulin Sales Market Share (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Basic Information List
Table Actelion Pharmaceuticals Ltd. (Switzerland) Remodulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Remodulin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Remodulin
Figure Manufacturing Process Analysis of Remodulin
Figure Remodulin Industrial Chain Analysis
Table Raw Materials Sources of Remodulin Major Manufacturers in 2015
Table Major Buyers of Remodulin
Table Distributors/Traders List
Figure United States Remodulin Production and Growth Rate Forecast (2016-2021)
Figure United States Remodulin Revenue and Growth Rate Forecast (2016-2021)
Table United States Remodulin Production Forecast by Type (2016-2021)
Table United States Remodulin Consumption Forecast by Application (2016-2021)